A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1999
12/15/1999	CN1047385C 3-indolylpiperidine and medinal composition containing them
12/14/1999	US6002009 Di-substituted 1,4-piperidine esters and amides having 5-HT4 antagonistic activity
12/14/1999	US6002002 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001970 Modified human neuropeptide Y1 Receptors
12/14/1999	US6001961 Cyclic adhesion inhibitors
12/14/1999	US6001881 Administering to treat arrhythmia, angina pectoris, ischemia, shock, cell proliferation, fibrotic diseases, prostate hyperplasia, fat metabolism disorders, and as a preservative for transplant organs, or to prepare a patient for surgery
12/14/1999	US6001860 N-heteroaryl substituted thiourea or urea derivatives used to reduce cholesterol in blood stream, therefore useful to prevent cardiovascular disorders
12/14/1999	US6001855 Thiazole derivatives
12/14/1999	US6001849 Furopyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmission
12/14/1999	US6001832 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
12/14/1999	US6001830 Heterocyclic compounds
12/14/1999	US6001802 Antiproliferative agents
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001350 Genetic modification of endothelial cells
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2172137C Surface loop structural analogues of fibroblast growth factors
12/14/1999	CA2135487C Heteroaromatic quinuclidinenes, their use and preparation
12/14/1999	CA2010636C Substituted pyrroles
12/12/1999	CA2274202A1 Diaza-spiro[3,5]nonane derivatives
12/09/1999	WO1999063070A1 Human protein c polypeptide
12/09/1999	WO1999062904A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	WO1999062902A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/09/1999	WO1999062891A1 Potassium channel inhibitors
12/09/1999	WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999	WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999	WO1999062872A1 New 3-aryl-2-hydroxypropionic acid derivative (i)
12/09/1999	WO1999062870A1 New 3-aryl-2-hydroxypropionic acid derivative iii
12/09/1999	WO1999062560A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999	WO1999062551A1 Texaphyrin conjugates and uses thereof
12/09/1999	WO1999062549A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999	WO1999062543A1 Composition based on pentoxifylline and anticytokin
12/09/1999	WO1999062539A1 Lysine containing peptides for treatment of heart disease
12/09/1999	WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999	WO1999062529A1 Pharmaceutical or cosmetic composition and method for cosmetic treatment of angiogenic disorders
12/09/1999	WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999	WO1999062518A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
12/09/1999	WO1999062507A1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
12/09/1999	WO1999062506A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/09/1999	WO1999062505A2 Method for treating neurodegenerative disorders
12/09/1999	WO1999062504A2 Topical administration of oxazolidinones for transdermal delivery
12/09/1999	WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999	WO1999062359A1 Matthiola seed oil, mixtures containing it and use thereof
12/09/1999	WO1999051260A3 Treatment of cardiac hypertrophy
12/09/1999	WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
12/09/1999	WO1999046367A3 Methods of diagnosis and triage using cell activation measures
12/09/1999	WO1999026583A3 Inhibtion of lipoprotein oxidation
12/09/1999	WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999	DE19825494A1 Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben The same new angiotensin receptor preparation and use
12/09/1999	CA2334809A1 Texaphyrin conjugates and uses thereof
12/09/1999	CA2334258A1 Potassium channel inhibitors
12/09/1999	CA2334107A1 New 3-aryl-2-hydroxypropionic acid derivative iii
12/09/1999	CA2333994A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	CA2333988A1 Matthiola seed oil, mixtures containing it and use thereof
12/09/1999	CA2333975A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999	CA2333776A1 Composition based on pentoxifylline and anticytokin
12/09/1999	CA2333756A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/09/1999	CA2330581A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999	CA2330567A1 Lysine containing peptides for treatment of heart disease
12/09/1999	CA2330171A1 Human protein c polypeptide
12/09/1999	CA2327326A1 Topical administration of oxazolidinones for transdermal delivery
12/08/1999	EP0962529A1 Synthesis of human procollagens and collagens in recombinant DNA systems
12/08/1999	EP0961835A1 Method for identifying selective inhibitors of nitric oxide synthase
12/08/1999	EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999	EP0961618A1 Novel compounds
12/08/1999	EP0600970B1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
12/08/1999	CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use
12/08/1999	CN1237963A Qinoline derivatives inhibiting effect of growth factors such as VEGF
12/08/1999	CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/08/1999	CN1237955A Substituted phenols and thiophenols useful as antioxidant agents
12/08/1999	CN1237904A New use of creatine
12/08/1999	CN1237419A Pharmaceutical process of crocus sativus polyglycoside and its tablet
12/08/1999	CN1237417A Controlled drug delivery system for diltiazem
12/08/1999	CN1047169C Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives, and its use and medicinal preparation
12/07/1999	US5998666 Phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same
12/07/1999	US5998583 BH3 interacting domain death agonist
12/07/1999	US5998579 Epimorphin antagonist and process for producing it
12/07/1999	US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999	US5998474 Reduction of oxygen free radicals; nervous system disorders,cardiovascular disorders
12/07/1999	US5998458 Administering inotropic agent and adrenergic receptor antagonist
12/07/1999	US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999	US5998401 Naphthyl compounds, intermediates, compositions, and methods
12/07/1999	US5998400 Atherosclerosis
12/07/1999	US5998390 Combination of bisphosphonate and tetracycline
12/07/1999	US5998388 Adenosine derivatives
12/07/1999	US5998387 Method for using A1 adenosine receptor agonists
12/07/1999	US5998137 To assess predisposition or susceptibility to a number of diseases: osteoporosis, atherosclerosis, cancer and immune disorders.
12/07/1999	US5997863 Attenuation of wound healing processes
12/07/1999	US5997861 Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
12/07/1999	CA2198231C Dihydropyridine derivatives as bradykinin antagonists
12/07/1999	CA2157410C Enhanced circulation effector composition and method
12/07/1999	CA2140768C A method of increasing creatine supply depot
12/07/1999	CA2013037C Aminobenzenesulfonic acid derivative
12/07/1999	CA2012686C Treatment and compounds
12/02/1999	WO1999061617A1 Interleukins-21 and 22
12/02/1999	WO1999061476A1 Peptide antiangiogenic drugs
12/02/1999	WO1999061471A2 Human transmembrane proteins
12/02/1999	WO1999061444A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/02/1999	WO1999061442A1 Imidazopyridine thrombin inhibitors
12/02/1999	WO1999061440A1 Novel substituted imidazole compounds

1 ... 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 ... 1595